Search alternatives:
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
45321
Image 9_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg
Published 2025“…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I<sup>2</sup> = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I<sup>2</sup> = 0%, p=0.98) exhibited an increase in TT levels. …”
-
45322
Image 6_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg
Published 2025“…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I<sup>2</sup> = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I<sup>2</sup> = 0%, p=0.98) exhibited an increase in TT levels. …”
-
45323
Image 10_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg
Published 2025“…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I<sup>2</sup> = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I<sup>2</sup> = 0%, p=0.98) exhibited an increase in TT levels. …”
-
45324
Image 1_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg
Published 2025“…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I<sup>2</sup> = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I<sup>2</sup> = 0%, p=0.98) exhibited an increase in TT levels. …”
-
45325
Image 3_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg
Published 2025“…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I<sup>2</sup> = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I<sup>2</sup> = 0%, p=0.98) exhibited an increase in TT levels. …”
-
45326
Image 8_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg
Published 2025“…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I<sup>2</sup> = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I<sup>2</sup> = 0%, p=0.98) exhibited an increase in TT levels. …”
-
45327
Image 7_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg
Published 2025“…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I<sup>2</sup> = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I<sup>2</sup> = 0%, p=0.98) exhibited an increase in TT levels. …”
-
45328
Image 4_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg
Published 2025“…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I<sup>2</sup> = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I<sup>2</sup> = 0%, p=0.98) exhibited an increase in TT levels. …”
-
45329
Image 2_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg
Published 2025“…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I<sup>2</sup> = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I<sup>2</sup> = 0%, p=0.98) exhibited an increase in TT levels. …”
-
45330
Data_Sheet_1_A Perioperative Paradigm of Cranioplasty With Polyetheretherketone: Comprehensive Management for Preventing Postoperative Complications.CSV
Published 2022“…Notably, patients who received the evolving paradigm presented a significantly decreased incidence of postoperative complications from 47.4 to 18.2% (P < 0.01), among which the incidences of subcutaneous effusion, epidural hematoma, and subcutaneous infection decreased significantly.…”
-
45331
Data_Sheet_1_Cryoballoon ablation guided by a novel wide-band dielectric imaging system.DOCX
Published 2022“…Median fluoroscopy time was decreased by 6.4 min (37.3%), and the median volume of dye was decreased by 32.5 ml (52%) from versions 1.4.6 to 1.4.8. …”
-
45332
Table_1_Neural Correlates of Food Cue Exposure Intervention for Obesity: A Case-Series Approach.docx
Published 2020“…</p>Objectives<p>It was hypothesized that participants after food cue exposure therapy would show reduced neural activity in brain regions related to food cue reactivity and increased neural activity in brain regions related to inhibitory-control as compared to participants receiving a control lifestyle intervention.</p>Method<p>Neural activity of 10 women with overweight (BMI ≥ 27 kg/m<sup>2</sup>) in response to individually tailored visually presented palatable high-caloric food stimuli was examined before vs. after a cue exposure intervention (n = 5) or a control lifestyle (n = 5) intervention. …”
-
45333
Skeletal Muscle Lipidomics as a New Tool to Determine Altered Lipid Homeostasis in Fish Exposed to Urban and Industrial Wastewaters
Published 2019“…The targeted analysis consistently detected a decrease in PC-plasmalogens (36:4, 36:6, 38:6) and highly unsaturated PCs (36:5, 36:6, 38:6, 40:6, 40:7) and an increase in plasmanyl-PCs (36:5, 38:5), lyso-PCs (16:1, 18:1, 22:4) and cholesteryl esters (CEs) (16:0, 18:0, 20:4) in fish from polluted sites. …”
-
45334
-
45335
-
45336
Supplementary Material for: The effect of enzymatic treatment with mutanase, beta-glucanase and DNase on a saliva-derived biofilm model
Published 2024“…Introduction: The dental biofilm matrix is an important determinant of virulence for caries development and comprises a variety of extracellular polymeric substances that contribute to biofilm stability. …”
-
45337
Data_Sheet_1_Altered functional connectivity and regional brain activity in a triple-network model in minimally conscious state and vegetative-state/unresponsive wakefulness syndro...
Published 2022“…These findings contribute to a better understanding of the underlying neural mechanism of functional connectivity and regional brain activity in DOC patients, and this triple-network model provides new connectivity pattern changes that may be integrated in future diagnostic tools based on the neural signatures of conscious states.…”
-
45338
DataSheet1_Evaluating plantar biomechanics while descending a single step with different heights.XLSX
Published 2024“…</p>Results<p>At 5 cm and 15 cm steps, participants demonstrated a rearfoot landing strategy on both sides. …”
-
45339
Image_1_LesionQuant for Assessment of MRI in Multiple Sclerosis—A Promising Supplement to the Visual Scan Inspection.TIFF
Published 2020“…</p><p>Methods: A group of 56 MS patients (mean age 35 years, 70% females and 96% relapsing-remitting MS) was examined with brain MRI one and 5 years after diagnosis. …”
-
45340
Image_2_LesionQuant for Assessment of MRI in Multiple Sclerosis—A Promising Supplement to the Visual Scan Inspection.TIFF
Published 2020“…</p><p>Methods: A group of 56 MS patients (mean age 35 years, 70% females and 96% relapsing-remitting MS) was examined with brain MRI one and 5 years after diagnosis. …”